Paysign stock analysis
Want to see PAYS full AI Analyst Report?
Paysign (PAYS) Stock Price & Analysis
PAYS Stock Chart & Stats
- Day’s Range
- $9.98 - $10.37
- 52-Week Range
- $3.08 - $16.15
- Previous Close
- $10.07
- Volume
- N/A
- Average Volume (3M)
- 1.23M
- Market Cap
- $571.95M
- Enterprise Value
- $614.62M
- Total Cash (Recent Filing)
- $34.54M
- Total Debt (Recent Filing)
- $5.50M
- Price to Earnings (P/E)
- 27.6
- Beta
- 1.42
- Next Earnings
- Mar 23, 2027 (Est.)
- EPS Estimate
- 0.07
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Patient Affordability Growth
Rapid growth in patient affordability revenue and a larger program base indicate strong adoption of Paysign’s healthcare payments platform. Continued launches, maturation of existing programs and pharmaceutical relationship expansion can support recurring, scalable revenue over the next several quarters.
Margin Expansion And Operating Leverage
Sharp margin expansion shows that revenue growth is translating into disproportionate profit growth as higher-margin pharmaceutical services increase their mix. Expense growth below revenue growth and a raised profitability outlook support the durability of operating leverage.
Strong Cash Generation And Low Leverage
Robust free cash flow closely tracking earnings gives Paysign resources to fund product development, support client programs and pursue expansion without relying heavily on external financing. Very low leverage also preserves flexibility through changing business conditions.
Bears Say
Loss Of 113 Plasma Centers
The center transition reduces the scale of Paysign’s plasma processing business and removes an established source of program and transaction revenue. Although some centers remain, the event demonstrates that client decisions can create meaningful structural pressure on an important business line.
Apherion Regulatory Uncertainty
Pending regulatory approval delays the timing of Apherion commercialization and leaves the potential contribution from the donor management system uncertain. A slower review could postpone European and broader product expansion, limiting near-term diversification beyond existing programs.
Revenue Growth Deceleration
A material slowdown in top-line growth raises the importance of new program wins and successful product expansion to sustain earnings momentum. If moderate growth persists while the asset base expands, maintaining returns and the current profitability trajectory may become more difficult.
Paysign News
PAYS FAQ
What was Paysign’s price range in the past 12 months?
What is Paysign’s market cap?
When is Paysign’s upcoming earnings report date?
How were Paysign’s earnings last quarter?
Is Paysign overvalued?
Does Paysign pay dividends?
What is Paysign’s EPS estimate?
How many shares outstanding does Paysign have?
What happened to Paysign’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Paysign?
What is the TipRanks Smart Score and how is it calculated?
Paysign Stock Smart Score
Company Description
Paysign
Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card and software solutions. It also operates a customer service center; and offers a communication suite, including mobile app, two-way SMS, text alerts, and cardholder web portal. The company markets its prepaid card solutions under the Paysign brand. It serves companies and municipalities that require payment solutions for rewards, rebates, payment assistance, and other payments to their customers, employees, agents, and others. Paysign, Inc. was founded in 2001 and is headquartered in Henderson, Nevada.
- Sector
- Technology
- Industry
- Specialty Business Services
- CEO
- Mark Newcomer
- Employees
- 226
- Website
- www.paysign.com
- Address
- 2615 St. Rose Parkway, Henderson, NV, 89052, US
Paysign (PAYS) Earnings & Revenues
PAYS Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Record revenue and profitability, more than doubling patient affordability revenue, substantial program and claim growth, significant margin expansion, strong client savings and raised full-year profitability expectations substantially outweighed the loss of 113 plasma centers, the related fourth-quarter financial impact, the higher tax rate and the pending Apherion regulatory review.
View all PAYS earnings summariesPAYS Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 4 | 10 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 4 | 0 | 8 |












